Psychiatry & Neurology Doctors in Georgetown, MA Accepting Medicare
4 Psychiatry & Neurology doctors found. Showing 1 - 4
 Rajendra M Trivedi, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 83 Baldpate Rd, Georgetown, MA 01833 Phone: 781-376-1771 |
Dr. Manuel S Valencia, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 83 Baldpate Rd, Georgetown, MA 01833 Phone: 978-353-2131 Fax: 978-352-6755 |
Richard R Cooper, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 83 Baldpate Rd, Georgetown, MA 01833 Phone: 978-352-2131 |
Leo M Shapiro, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 90 Baldpate Rd, Georgetown, MA 01833 Phone: 978-352-4038 |
News Archive
Seattle Genetics starts Brentuximab Vedotin retreatment trial
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
Study: Free-range eggs may not be healthier than regular eggs
Contrary to popular belief, paying a premium price for free-range eggs may not be healthier than eating regular eggs, a new study reports. Scientists found that free-range eggs in Taiwan contain at least five times higher levels of certain pollutants than regular eggs. Their findings appear in ACS' bi-weekly Journal of Agricultural and Food Chemistry.
Anapharm Europe, PharmaNet officially terminate joint venture
PharmaNet Development Group, and Anapharm Europe, S.L., both leading providers of drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries, announced that their joint venture for the collaborative provision of bioanalytical services officially ended December 22, 2010.
Research opens treatment pathways for cancers that do not respond to targeted antibodies
By hijacking a cancer cell's own metabolism, researchers have found a way to tag and target elusive cancers with small-molecule sugars. This opens treatment pathways for cancers that are not responsive to conventional targeted antibodies, such as triple-negative breast cancer.
› Verified 6 days ago